Home/ Stocks/ TECX

Tectonic Therapeutic, Inc. Common Stock

TECX XNAS

$29.00 +2.63 (+9.79%) ▲ 15-min delayed

Open

$27.00

High

$30.36

Low

$27.00

Volume

432.7K

Market Cap

$547.21M

About Tectonic Therapeutic, Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 60 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$-26,194,000	$-25,241,000	$-1.34
FY 2025	$-80,321,000	$-74,151,000	$-4.05
Q3 2025	$0	$-19,035,000	$-1.02
Q2 2025	$0	$-19,984,000	$-1.07

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026

Calendar →

Related Market News

No specific coverage for TECX yet. Check out our latest market news or earnings calendar.

Get TECX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Tectonic Therapeutic, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.